Clovis Oncology Inc
Change company Symbol lookup
Select an option...
CLVS Clovis Oncology Inc
TLOG TetraLogic Pharmaceuticals Corp
JPM-K JPMorgan Chase & Co
KLAC KLA Corp
CNVY Convey Health Solutions Holdings Inc
EBAY eBay Inc
PRLX Parallax Health Sciences Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Clovis Oncology, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and additional international markets. Its segments include U.S. and ex-U.S. Its product, Rubraca, is an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP) marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer and an indication specific to metastatic castration-resistant prostate cancer (mCRPC). Its FAP-2286, is an investigational diagnostic and therapeutic agent targeting fibroblast activation protein (FAP). It also provides Lucitanib, which is an investigational, oral, potent angiogenesis inhibitor, which inhibits vascular endothelial growth factor receptors 1 through 3 (VEGFR1-3), platelet-derived growth factor receptors alpha and beta (PDGFR α/β) and fibroblast growth factor receptors 1 through 3 (FGFR1-3).

Closing Price
$1.27
Day's Change
-0.18 (-12.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.44
Day's Low
1.20
Volume
(Heavy Day)
Volume:
4,516,597

10-day average volume:
3,598,494
4,516,597
  • Prev Close
    1.45
  • Today's Open
    1.44
  • Day's Range
    1.20-1.44
  • Avg Vol (10-day)
    3.6M
  • Last (time)
    4:00p ET 08/09/22
  • Last (size)
    306
  • 52-Wk Range
    0.581 - 5.06
    LowHigh
  • (08/09/21 - 06/13/22)
    118.59%
  • 127.4%
  • Market Cap
    182.7M
  • Shares Outstanding
    143.9M
  • -2.11
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.4
  • 38.55
  • (% of float 07/15/22)
    20.15

Latest News

August 08, 2022
8:00 am ET
BusinessWire
July 20, 2022
6:06 pm ET
BusinessWire
4:00 pm ET
BusinessWire
July 19, 2022
8:30 am ET
BusinessWire
July 13, 2022
10:55 am ET
PR Newswire
July 08, 2022
9:31 am ET
PR Newswire
July 05, 2022
11:18 am ET
PR Newswire
June 30, 2022
9:31 am ET
PR Newswire
June 22, 2022
9:31 am ET
PR Newswire
June 21, 2022
8:30 am ET
PR Newswire
June 15, 2022
8:30 am ET
PR Newswire
June 14, 2022
2:00 pm ET
BusinessWire
11:10 am ET
PR Newswire
June 06, 2022
8:00 am ET
BusinessWire
March 31, 2022
8:01 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.